Dyskinesia Severity Estimation in Patients with Parkinson’s Disease Using Wearable Sensors and A Deep LSTM Network

Dyskinesias are abnormal involuntary movements that patients with mid-stage and advanced Parkinson’s disease (PD) may suffer from. These troublesome motor impairments are reduced by adjusting the dose or frequency of medication levodopa. However, to make a successful adjustment, the treating physician needs information about the severity rating of dyskinesia as patients experience in their natural living environment. In this work, we used movement data collected from the upper and lower extremities of PD patients along with a deep model based on Long Short-Term Memory to estimate the severity of dyskinesia. We trained and validated our model on a dataset of 14 PD subjects with dyskinesia. The subjects performed a variety of daily living activities while their dyskinesia severity was rated by a neurologist. The estimated dyskinesia severity ratings from our developed model highly correlated with the neurologist-rated dyskinesia scores (r=0.86 (p<0.001) and 1.77 MAE (6%)) indicating the potential of the developed the approach in providing the information required for effective medication adjustments for dyskinesia management.

[1]  J. J. van Hilten,et al.  Accelerometric assessment of levodopa‐induced dyskinesias in Parkinson's disease , 2001, Movement disorders : official journal of the Movement Disorder Society.

[2]  C. Goetz,et al.  Levodopa‐induced dyskinesias , 2007, Movement disorders : official journal of the Movement Disorder Society.

[3]  J. Nutt,et al.  The Unified Dyskinesia Rating Scale: Presentation and clinimetric profile , 2008, Movement disorders : official journal of the Movement Disorder Society.

[4]  J. Jankovic Parkinson’s disease: clinical features and diagnosis , 2008, Journal of Neurology, Neurosurgery, and Psychiatry.

[5]  Paolo Bonato,et al.  Monitoring Motor Fluctuations in Patients With Parkinson's Disease Using Wearable Sensors , 2009, IEEE Transactions on Information Technology in Biomedicine.

[6]  J. Giuffrida,et al.  Objective motion sensor assessment highly correlated with scores of global levodopa-induced dyskinesia in Parkinson's disease. , 2013, Journal of Parkinson's disease.

[7]  D. Heldman,et al.  Motion sensor dyskinesia assessment during activities of daily living. , 2014, Journal of Parkinson's disease.

[8]  Wojciech Zaremba,et al.  Recurrent Neural Network Regularization , 2014, ArXiv.

[9]  Jimmy Ba,et al.  Adam: A Method for Stochastic Optimization , 2014, ICLR.

[10]  Joan Cabestany,et al.  Dopaminergic-induced dyskinesia assessment based on a single belt-worn accelerometer , 2016, Artif. Intell. Medicine.

[11]  Jerker Westin,et al.  A Treatment-Response Index From Wearable Sensors for Quantifying Parkinson's Disease Motor States , 2018, IEEE Journal of Biomedical and Health Informatics.

[12]  B. Bloem,et al.  The Emerging Evidence of the Parkinson Pandemic , 2018, Journal of Parkinson's disease.

[13]  Michelle A. Burack,et al.  Symptom-based, Dual-channel LSTM Network for The Estimation of Unified Parkinson's Disease Rating Scale III , 2019, 2019 IEEE EMBS International Conference on Biomedical & Health Informatics (BHI).

[14]  G. Ó. Laighin,et al.  Estimating dyskinesia severity in Parkinson’s disease by using a waist-worn sensor: concurrent validity study , 2019, Scientific Reports.